AKT1 and lung carcinoma: miR-7 is also shown to target phosphoinositide-3-kinase regulatory subunit 3 (PIK3R3) in lung cancer cells, and the down-regulation of the PIK3R3/Akt pathway attenuates the TLR9 signaling-induced growth and proliferation of lung cancer cells [107].